200 related articles for article (PubMed ID: 31764175)
41. Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target.
Yan Y; Zuo X; Wei D
Stem Cells Transl Med; 2015 Sep; 4(9):1033-43. PubMed ID: 26136504
[TBL] [Abstract][Full Text] [Related]
42. Aberrant alternative splicing of RHOA is associated with loss of its expression and activity in diffuse-type gastric carcinoma cells.
Miyamoto S; Nagamura Y; Nakabo A; Okabe A; Yanagihara K; Fukami K; Sakai R; Yamaguchi H
Biochem Biophys Res Commun; 2018 Jan; 495(2):1942-1947. PubMed ID: 29247652
[TBL] [Abstract][Full Text] [Related]
43. Differential roles of protease isoforms in the tumor microenvironment.
Liyanage C; Fernando A; Batra J
Cancer Metastasis Rev; 2019 Sep; 38(3):389-415. PubMed ID: 31673830
[TBL] [Abstract][Full Text] [Related]
44. Aberrant Splicing in Cancer: Mediators of Malignant Progression through an Imperfect Splice Program Shift.
Luz FA; Brígido PC; Moraes AS; Silva MJ
Oncology; 2017; 92(1):3-13. PubMed ID: 27794578
[TBL] [Abstract][Full Text] [Related]
45. Genetic variants of mucins: unexplored conundrum.
Kumar S; Cruz E; Joshi S; Patel A; Jahan R; Batra SK; Jain M
Carcinogenesis; 2017 Jul; 38(7):671-679. PubMed ID: 27838635
[TBL] [Abstract][Full Text] [Related]
46. WT1 interacts with the splicing protein RBM4 and regulates its ability to modulate alternative splicing in vivo.
Markus MA; Heinrich B; Raitskin O; Adams DJ; Mangs H; Goy C; Ladomery M; Sperling R; Stamm S; Morris BJ
Exp Cell Res; 2006 Oct; 312(17):3379-88. PubMed ID: 16934801
[TBL] [Abstract][Full Text] [Related]
47. Tissue stiffness regulates serine/arginine-rich protein-mediated splicing of the extra domain B-fibronectin isoform in tumors.
Bordeleau F; Califano JP; Negrón Abril YL; Mason BN; LaValley DJ; Shin SJ; Weiss RS; Reinhart-King CA
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8314-9. PubMed ID: 26106154
[TBL] [Abstract][Full Text] [Related]
48. RNA components of the spliceosome regulate tissue- and cancer-specific alternative splicing.
Dvinge H; Guenthoer J; Porter PL; Bradley RK
Genome Res; 2019 Oct; 29(10):1591-1604. PubMed ID: 31434678
[TBL] [Abstract][Full Text] [Related]
49. Analysis of alternative splicing events for cancer diagnosis using a multiplexing nanophotonic biosensor.
Huertas CS; Domínguez-Zotes S; Lechuga LM
Sci Rep; 2017 Jan; 7():41368. PubMed ID: 28120920
[TBL] [Abstract][Full Text] [Related]
50. Alternative transcription and alternative splicing in cancer.
Pal S; Gupta R; Davuluri RV
Pharmacol Ther; 2012 Dec; 136(3):283-94. PubMed ID: 22909788
[TBL] [Abstract][Full Text] [Related]
51. Splicing factor poly(rC)-binding protein 1 is a novel and distinctive tumor suppressor.
Guo J; Jia R
J Cell Physiol; 2018 Jan; 234(1):33-41. PubMed ID: 30132844
[TBL] [Abstract][Full Text] [Related]
52. [RNA and cancer].
Jeanteur P
Bull Cancer; 2008 Jan; 95(1):33-41. PubMed ID: 18230568
[TBL] [Abstract][Full Text] [Related]
53. Neuronal proteins custom designed by alternative splicing.
Lipscombe D
Curr Opin Neurobiol; 2005 Jun; 15(3):358-63. PubMed ID: 15961039
[TBL] [Abstract][Full Text] [Related]
54. Candidates for tumor-specific alternative splicing.
Okumura M; Kondo S; Ogata M; Kanemoto S; Murakami T; Yanagida K; Saito A; Imaizumi K
Biochem Biophys Res Commun; 2005 Aug; 334(1):23-9. PubMed ID: 16018876
[TBL] [Abstract][Full Text] [Related]
55. Alternative splicing in disease.
Orengo JP; Cooper TA
Adv Exp Med Biol; 2007; 623():212-23. PubMed ID: 18380349
[TBL] [Abstract][Full Text] [Related]
56. Generation of interleukin-17 receptor-like protein (IL-17RL) in prostate by alternative splicing of RNA.
Haudenschild DR; Curtiss SB; Moseley TA; Reddi AH
Prostate; 2006 Sep; 66(12):1268-74. PubMed ID: 16688746
[TBL] [Abstract][Full Text] [Related]
57. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
[TBL] [Abstract][Full Text] [Related]
58. Alternative splicing of DNA damage response genes and gastrointestinal cancers.
Rahmutulla B; Matsushita K; Nomura F
World J Gastroenterol; 2014 Dec; 20(46):17305-13. PubMed ID: 25516641
[TBL] [Abstract][Full Text] [Related]
59. Alternative RNA splicing in tumour heterogeneity, plasticity and therapy.
Öther-Gee Pohl S; Myant KB
Dis Model Mech; 2022 Jan; 15(1):. PubMed ID: 35014671
[TBL] [Abstract][Full Text] [Related]
60. Insight into the role of alternative splicing within the RBM10v1 exon 10 tandem donor site.
Tessier SJ; Loiselle JJ; McBain A; Pullen C; Koenderink BW; Roy JG; Sutherland LC
BMC Res Notes; 2015 Feb; 8():46. PubMed ID: 25889998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
